Key result
After controlling for insulin sensitivity, African-American women had a higher mean apoAI level in HDL with apoCIII compared with white women (12.9 vs 10.9 mg/dL, P=0.05).
Why the study?
Do African-American women have different postprandial apoCIII-containing lipoprotein profiles compared to white women when adjusting for insulin resistance and visceral adiposity?
Cross-Sectional (n=32)
No
Do African-American women have different postprandial apoCIII-containing lipoprotein profiles compared to white women when adjusting for insulin resistance and visceral adiposity?
Absolute Event Rate: 12.9% vs 10.9%
p-value: p=0.05
African-American women exhibit higher levels of atherogenic HDL containing apoCIII and lower levels of apoCIII in apoB lipoproteins compared to white women when adjusting for their lower insulin sensitivity, highlighting complex racial differences in lipid metabolism.
May warrant race-specific HDL assessment in women; leaves open whether apoCIII enrichment alters CVD risk or outcomes.
BACKGROUND: African-Americans have higher HDL, less visceral adipose tissue (VAT) and lower triglyceride (TG) and apoCIII concentrations than whites, despite being more insulin-resistant. We studied in African-American and white women the influences of insulin resistance and VAT on the apoAI concentrations of two HDL subspecies, one that contains apoCIII that is associated with increased risk of coronary heart disease (CHD) and one that does not have apoCIII that is associated with decreased CHD; and on the apoCIII concentrations of HDL and of the apoB lipoproteins. METHODS: The participants were 32 women (14 African-Americans, 18 white) of similar age (39 ± 12 vs. 42 ± 11y). Mean BMI was 34 kg/m(2) in the African-Americans compared to 30 in the whites. A standard diet (33% fat, 52% carbohydrate, 15% protein) was provided for 7 days followed by a test meal (40% fat, 40% carbohydrate, 20% protein) on Day 8. Insulin sensitivity index (SI) was calculated from the minimal model. RESULTS: After controlling for SI, African-Americans have a higher mean apoAI level in HDL with apoCIII compared with whites (12.9 ± 2.8 and 10.9 ± 2.9 mg/dL, respectively, P = 0.05). SI was associated with higher apoAI in HDL with apoCIII, whereas VAT was not associated with this HDL subspecies. This pattern of results was reversed for apoCIII concentrations in apoB lipoproteins. After adjusting for SI, African-Americans had lower apoCIII in apoB lipoproteins. SI was associated with lower apoCIII in total apoB lipoproteins, whereas VAT was associated with higher apoCIII in all the apoB lipoproteins. Additional adjustment for VAT tended to reduce the difference in apoCIII between the groups. CONCLUSIONS: African-American women have a higher HDL with apoCIII level than whites when controlled for insulin sensitivity. African-Americans have lower insulin sensitivity. Insulin sensitivity is associated with higher levels of HDL with apoCIII. ApoCIII levels in VLDL are lower in African-American women than whites, also affected by insulin sensitivity which is associated with low apoCIII in VLDL. VAT has a strong association with apoCIII in apoB lipoproteins but not with apoAI in HDL with apoCIII. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00484861.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted a cross-sectional in Nondiabetic (n=32). African-American race vs. White race was evaluated on Mean apoAI level in HDL with apoCIII after controlling for insulin sensitivity (p=0.05). After controlling for insulin sensitivity, African-American women had a higher mean apoAI level in HDL with apoCIII compared with white women (12.9 vs 10.9 mg/dL, P=0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: